Logo
x

Search

Subscribe Now

allergic asthma

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

  • April 13, 2021
Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

  • August 13, 2020
Roche Reports the US FDA

    Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

    • August 13, 2020
    Novartis

      Novartis' Xolair (omalizumab) Receives EU's Approval for Severe Allergic Asthma (SAA) and Chronic Spontaneous Urticaria (CSU)

      • December 14, 2018
      Image

      Incisive News in 3 Shots.

      Contact Us

      Our Information

      Follow Us

      Copyright © 2025 PharmaShots - All Rights Reserved.